Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Max Planck Institute of Psychiatry, Munich, Germany.
Current research suggests an involvement of 5-HT3 receptors in peripheral and central perception and processing of pain as well as in inflammation. Tropisetron and other selective 5-HT3 receptor antagonists have been used successfully for pain reduction and treatment of related symptoms in patients diagnosed with fibromyalgia. This article proposes a concept of the underlying pathophysiology and mechanisms of action of 5-HT3 receptor antagonists in the context of the relevant clinical data on their application in patients with rheumatic disease.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on